12 completed, 7 unknown, 2 active not recruiting, 1 not yet recruiting. 9 Phase 3, 7 Phase 2, 4 Phase 1, 3 Phase 4, 2 Not applicable.
Follow Placebo 2: new trials by email Literature Review of Placebo 2 trials Research Report on Placebo 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Vitamin D and Branched-chain Amino Acids on Physical Performance and Biomarkers of Muscle Fatigue in Runners Training program, Branched-Chain Amino Acids, Vitamin D - Healthy Adult Male, Runners | Not applicable | Not yet recruiting | Pedro Julian Flores Moreno | 64 | 2026-01-01 | 2026-01-12 |
| A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa Remibrutinib Dose A, Remibrutinib Dose B, Placebo 1 - Hidradenitis Suppurativa | Phase 3 | Active not recruiting | Novartis Pharmaceuticals | 565 | 2025-03-20 | 2026-10-15 |
| A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1) Remibrutinib Dose A, Remibrutinib Dose B, Placebo 1 - Hidradenitis Suppurativa | Phase 3 | Active not recruiting | Novartis Pharmaceuticals | 588 | 2025-01-31 | 2026-10-15 |
| Neurobiological Drivers of Mobility Resilience: The Dopaminergic System - Placebo-Controlled Arm Carbidopa 25 mg, Carbidopa-Levodopa 25/100 mg, Placebo 1 - Parkinsonian Signs in Older Persons | Phase 1 / Phase 2 | Completed | University of Michigan | 13 | 2024-03-15 | 2025-06-17 |
| Effects of Probiotics on Metabolic Syndrome ,Intestinal Microflora and SCFA. Probiotics 1, Probiotics 2, Probiotics 3 - Metabolic Syndrome | Not applicable | Completed | Glac Biotech Co., Ltd | 82 | 2021-08-01 | 2023-12-28 |
| A Multi-center, Double-blinding, Parallel and Positive-controlled Phase III Clinical Trial for Efficacy and Safety Evaluation of Ilaprazole Sodium for Injection on Prevention of Stress Ulcer Bleeding Esomeprazole 40mg, Ilaprazole Sodium, Placebo 1 - Stress Ulcer Bleeding | Phase 3 | Completed | Livzon Pharmaceutical Group Inc. | 449 | 2021-07-16 | 2023-05-03 |
| A Phase 2 Study to Evaluate Pregabalin and Acetaminophen Compared to Acetaminophen and Placebo in Subjects Undergoing Bunionectomy Pregabalin, Acetaminophen, Placebo 1 - Postoperative Pain | Phase 2 | Completed | Nevakar, Inc. | 87 | 2020-07-28 | 2021-11-23 |
| Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease Otilimab, Placebo 1, Placebo 2 - Severe Acute Respiratory Syndrome | Phase 2 | Completed | GlaxoSmithKline | 1156 | 2020-05-28 | 2024-09-23 |
| PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM) PRO-122, Timolol eye drops, Dorzolamide-Timolol Ophthalmic - Primary Open-angle Glaucoma | Phase 3 | Terminated | Laboratorios Sophia S.A de C.V. | 51 | 2017-11-06 | 2025-03-06 |
| Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder ACT-541468 5 mg, ACT-541468 10 mg, ACT-541468 25 mg - Insomnia Disorder | Phase 2 | Completed | Idorsia Pharmaceuticals Ltd. | 360 | 2016-10-04 | 2020-04-13 |
| Tramadol Versus Celecoxib in Reducing Pain Associated With IUD Insertion Tramadol, Celecoxib, Placebo 1 - Pain | Phase 4 | Unknown | Cairo University | 210 | 2016-07-01 | 2019-04-08 |
| Combined Dehydropeiandrosterone and Growth Hormone in Women With Expected Poor Ovarian Response Undergoing ICSI DHEA, Growth hormone, Placebo 1 - Subfertility | Phase 4 | Unknown | Cairo University | 230 | 2016-06-01 | 2018-01-03 |
| A Clinical Research of Qi Deficiency and Blood Stasis Syndrome (Different Disease With Syndrome) Yiqi prescription, Huoxue prescription, Buyang huanwu decoction - Ischemic Heart Failure | Phase 2 | Unknown | Zhu Mingjun | 180 | 2016-06-01 | 2016-08-23 |
| Dehydroepiandrosterone Versus Growth Hormone in Women Undergoing ICSI With Expected Poor Ovarian Response DHEA, Growth Hormone-Releasing Hormone, Placebo 1 - Subfertility | Phase 3 | Unknown | Cairo University | 210 | 2016-06-01 | 2016-07-06 |
| Tramadol Versus Celecoxib for Reducing Pain During Office Hysteroscopy in Post Menopausal Women Celecoxib, Tramadol, Placebo 1 - Hysteroscopy | Phase 3 | Unknown | Cairo University | 210 | 2016-06-01 | 2016-07-06 |
| Tramadol Versus Celecoxib for Reducing Pain During Operative Office Hysteroscopy Celecoxib, Tramadol, Placebo 1 - Hysteroscopy | Phase 3 | Unknown | Cairo University | 210 | 2016-06-01 | 2016-07-06 |
| Monotherapy With Rapamycin in Long-standing Type 1 Diabetes rapamycin, Vildagliptin, Placebo 1 - Diabetes Mellitus, Type 1 | Phase 2 | Completed | Piemonti Lorenzo | 55 | 2016-05-01 | 2020-11-04 |
| Does Adding Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome? Fluoxetine, Combined oral contraceptives, Placebo 1 - Premenstrual Syndrome | Phase 3 | Unknown | Cairo University | 300 | 2015-10-01 | 2016-07-06 |
| An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic Patients VTP-43742, Placebo 1, Placebo 2 - Psoriasis | Phase 1 / Phase 2 | Completed | Vitae Pharmaceuticals Inc., an Allergan affiliate | 74 | 2015-08-01 | 2018-10-30 |
| Comparison Between Oral Contraceptive Pills and Calcium Supplements in Treatment of Premenstrual Syndrome Yasmin, Calver, Placebo 1 - Premenstrual Syndrome | Phase 3 | Completed | Beni-Suef University | 210 | 2014-05-01 | 2015-08-11 |
Showing 20 of 23. Sign in to see all of them.
Dermatitis (2) · Hidradenitis (2) · Hidradenitis Suppurativa (2) · Infertility (2) · Premenstrual Syndrome (2) · COVID-19 (1) · Coronary Artery Disease (1) · Coronavirus Infections (1) · Diabetes Mellitus, Type 1 (1) · Glaucoma (1) · Glaucoma, Open-Angle (1) · Metabolic Syndrome (1) · Pain (1) · Pain, Postoperative (1) · Psoriasis (1)
Cairo University (6) · Novartis Pharmaceuticals (3) · Beni-Suef University (1) · Glac Biotech Co., Ltd (1) · GlaxoSmithKline (1) · Idorsia Pharmaceuticals Ltd. (1) · Laboratorios Sophia S.A de C.V. (1) · Livzon Pharmaceutical Group Inc. (1) · Milton S. Hershey Medical Center (1) · Nevakar, Inc. (1) · Pedro Julian Flores Moreno (1) · Piemonti Lorenzo (1) · UCB Pharma (1) · University of Michigan (1) · Vitae Pharmaceuticals Inc., an Allergan affiliate (1)
United States (8) · Egypt (7) · Mexico (5) · Colombia (4) · Germany (4) · Spain (4) · Argentina (3) · Canada (3) · China (3) · Italy (3) · Poland (3) · United Kingdom (3) · Belgium (2) · France (2) · Greece (2)
AbdelGany M Hassan (3) · AbdelGany M Hassan, MRCOG, MD (1) · Abdelgany M Hassan, Lecturer (1) · Chatkaew Pongmala, PhD (1) · Devyani Chowdhury, MD (1) · Emanuele Bosi, MD (1) · Hsieh-Hsun Ho, Ph. D. (1) · Leopoldo Baiza, MD (1) · Li Bin (1) · Lorenzo Piemonti, MD (1) · Nesreen A Shehata, Lecturer (1) · Pedro J Flores Moreno, Doctor of Medical Sciences (1)
PMID 23741058, PMID 26808666, PMID 31953863, PMID 33124663, PMID 37477771, PMID 37526060, PMID 39046973, PMID 39175547, PMID 41737851
U01AG061393 (1)